Neupro Transdermal Patches 2mg/24h (Rotigotine PATCH) 2mg/24hrs

Neupro transdermal patches deliver rotigotine 2mg/24h for consistent relief. This non-oral option supports steady dopamine levels for symptom control. Ideal for those seeking alternative pain relief or movement support. Short-term use under medical guidance recommended.

Strength

2mg/24hrs

Manufacturer / TM Owner

UCB Pharma Pty Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rotigotine in Neupro patches is commonly used for pain relief associated with restless legs syndrome and supports movement control in Parkinson’s disease symptoms. It provides steady dopamine stimulation over 24 hours via skin absorption. Patients often ask what rotigotine patches are used for when exploring alternatives to oral medications.

Side Effects

Users typically report improved comfort and smoother daily routines when using Neupro patches. The gradual release helps maintain stable effects throughout the day and night. Some notice reduced nighttime restlessness or improved mobility with consistent application.

Precautions & Warnings

Apply Neupro patches to clean, dry, and intact skin on the abdomen, thigh, hip, flank, shoulder, or upper arm. Rotate application sites to avoid irritation and allow each area to recover between uses. Avoid exposing patches to heat sources like heating pads or prolonged sun exposure.

Avoid Interactions

Alcohol may enhance sedative effects when combined with rotigotine. Certain medications that affect liver enzymes, such as CYP inhibitors, can alter rotigotine levels in the body. Always inform healthcare providers about all medications and supplements being used.

Frequently Asked Questions

Each patch is designed to deliver medication continuously for 24 hours before replacement.

Patches should not be cut or altered; use as prescribed by a healthcare professional.

Replace it with a new patch at the next scheduled time; do not double up doses.

No, rotigotine is a dopamine agonist, while levodopa is a precursor to dopamine used in Parkinson’s treatment.

Consult a healthcare provider before using any medication during pregnancy or breastfeeding.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.